A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors.
Adult
Aged
Biomarkers, Tumor
/ genetics
Colorectal Neoplasms
/ diagnosis
DNA Mismatch Repair
/ genetics
Feasibility Studies
Female
Follow-Up Studies
Genetic Testing
Humans
Incidence
Male
Medical History Taking
Middle Aged
Mutation
ROC Curve
Registries
/ statistics & numerical data
Risk Assessment
/ methods
Risk Factors
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
23
08
2019
revised:
29
10
2019
accepted:
07
01
2020
pubmed:
15
1
2020
medline:
27
4
2021
entrez:
15
1
2020
Statut:
ppublish
Résumé
Reducing colorectal cancer incidence and mortality through early detection would improve efficacy if targeted. We developed a colorectal cancer risk prediction model incorporating personal, family, genetic, and environmental risk factors to enhance prevention. A familial risk profile (FRP) was calculated to summarize individuals' risk based on detailed cancer family history (FH), family structure, probabilities of mutation in major colorectal cancer susceptibility genes, and a polygenic component. We developed risk models, including individuals' FRP or binary colorectal cancer FH, and colorectal cancer risk factors collected at enrollment using population-based colorectal cancer cases ( The E/O [95% confidence interval (CI)] for FRP models for population-based relatives were 1.04 (0.74-1.45) for men and 0.86 (0.64-1.20) for women, and for clinic-based relatives were 1.15 (0.87-1.58) for men and 1.04 (0.76-1.45) for women. The age-adjusted AUCs (95% CI) for FRP models for population-based relatives were 0.69 (0.60-0.78) for men and 0.70 (0.62-0.77) for women, and for clinic-based relatives were 0.77 (0.69-0.84) for men and 0.68 (0.60-0.76) for women. The incremental values of AUC for FRP over FH models for population-based relatives were 0.08 (0.01-0.15) for men and 0.10 (0.04-0.16) for women, and for clinic-based relatives were 0.11 (0.05-0.17) for men and 0.11 (0.06-0.17) for women. Both models calibrated well. The FRP-based model provided better risk stratification and risk discrimination than the FH-based model. Our findings suggest detailed FH may be useful for targeted risk-based screening and clinical management.
Identifiants
pubmed: 31932410
pii: 1055-9965.EPI-19-0929
doi: 10.1158/1055-9965.EPI-19-0929
pmc: PMC7060114
mid: NIHMS1549629
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
549-557Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074799
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : N01PC35142
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA236558
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA097735
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074783
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074799
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074800
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074800
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074783
Pays : United States
Organisme : NCI NIH HHS
ID : N01 CN067009
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA170122
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA097735
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : K05 CA152715
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167551
Pays : United States
Informations de copyright
©2020 American Association for Cancer Research.
Références
Ann Intern Med. 2015 Sep 1;163(5):390-1
pubmed: 26258984
J Natl Cancer Inst. 2010 Feb 3;102(3):193-201
pubmed: 20028993
Theor Appl Genet. 1994 Jul;88(5):573-80
pubmed: 24186112
PLoS One. 2014 Feb 12;9(2):e88079
pubmed: 24533067
Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):398-410
pubmed: 22169185
Clin Gastroenterol Hepatol. 2014 Mar;12(3):478-85
pubmed: 24022090
Future Oncol. 2016 Feb;12(4):503-13
pubmed: 26846999
Hum Mutat. 2013 Mar;34(3):490-7
pubmed: 23255516
J Clin Gastroenterol. 2015 Jan;49(1):41-9
pubmed: 24583751
Eur J Cancer. 1995 Jul-Aug;31A(7-8):1033-8
pubmed: 7576987
Am J Epidemiol. 2006 Oct 1;164(7):697-705
pubmed: 16923773
N Engl J Med. 2004 Mar 4;350(10):991-1004
pubmed: 14999111
Genetics. 1997 Nov;147(3):1423-30
pubmed: 9383082
Gastroenterology. 2010 Mar;138(3):877-85
pubmed: 19932107
Gut. 2011 Sep;60(9):1236-41
pubmed: 21402615
Clin Epidemiol. 2018 Jan 19;10:143-152
pubmed: 29403313
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1580-1593
pubmed: 31292139
J Clin Oncol. 2009 Feb 10;27(5):686-93
pubmed: 19114701
Gastroenterology. 2018 Jun;154(8):2152-2164.e19
pubmed: 29458155
Ann Intern Med. 2008 Nov 4;149(9):659-69
pubmed: 18838717
Cancer Epidemiol. 2010 Oct;34(5):534-41
pubmed: 20554262
Int J Epidemiol. 2018 Apr 1;47(2):387-388i
pubmed: 29490034
Int J Cancer. 2020 Feb 1;146(3):627-634
pubmed: 30868574
Gastroenterology. 2008 Aug;135(2):419-28
pubmed: 18602922
JAMA. 2006 Sep 27;296(12):1479-87
pubmed: 17003396
Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):225-34
pubmed: 14973097
Am J Gastroenterol. 2018 Dec;113(12):1788-1800
pubmed: 30315282
Epidemiol Perspect Innov. 2011 Feb 27;8(1):2
pubmed: 21352566
Cancer Prev Res (Phila). 2016 Jan;9(1):13-26
pubmed: 26464100
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Clin Cancer Res. 1998 Oct;4(10):2371-6
pubmed: 9796967
Gut. 2019 Apr;68(4):672-683
pubmed: 29615487
Gastroenterology. 2018 Jul;155(1):88-98.e10
pubmed: 29574091
Cancer Causes Control. 2000 Jul;11(6):555-63
pubmed: 10880038
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43
pubmed: 17982118
Genet Med. 2015 Sep;17(9):702-12
pubmed: 25590981
Dig Dis Sci. 2017 Sep;62(9):2518-2525
pubmed: 28733868
Genet Med. 2011 May;13(5):385-91
pubmed: 21270638
J Natl Cancer Inst. 2005 May 18;97(10):715-23
pubmed: 15900041
Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
pubmed: 21037809
Gastroenterology. 2014 May;146(5):1208-11.e1-5
pubmed: 24444654
Am J Gastroenterol. 2019 Sep;114(9):1520-1530
pubmed: 31464746